English version of this page


Her vises en samlet oversikt over utvalgte publikasjoner for både hovedprosjektet og underprosjektene.

  • Establishment and charaterization of paired primary cultures of human pancreatic cancer cells and stellate cells derived from the same tumor. Amrutkar M, Larsen EK, Aasrum M, Finstadsveen AV, Andresen PA, Verbeke CS, Gladhaug IP. Cells 2020;16;9(1). pii:E227. Doi: 10.3390/cells9010227. PMID: 31963309
  • Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. Amrutkar M, Aasrum M, Verbeke CS, Gladhaug IP. BMC Cancer 2019;19(1):596. Doi: 10.1186/s12885-019-5803-1. PMID: 31208372
  • Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma. Misra S, Moro CF, Del Chiaro M, Pouso S, Sebestyén A, Löhr M, Björnstedt M, Verbeke CS. Sci Rep 2019;9:2133. Doi: 10.1038/s41598-019-38603-w. PMID: 30781677.
  • Commonly used pancreatic stellate cell cultures differ phenotypically and in their interactions with pancreatic cancer cells. Lenggenhager D, Amrutkar M, Sántha P, Aasrum M, Löhr JM, Gladhaug IP, Verbeke CS. Cells 2019;8:pii:E23. Doi: 10.3390/cells8010023. PMID: 30621293.
  • Pathology assessment of pancreatic cancer following neoduvant treatment: Time to move on. Verbeke C, Häberle L, Lenggenhager D, Esposito I. Pancreatology 2018 Apr 25. pii:S1424-3903(18)30077-2. Doi: 10.1016/j.pan.2018.04.010. PMID: 29843972.
  • Pancreatic cancer chemoresistance to gemcitabine. Amrutkar M, Gladhaug P. Cancers (Basel) 2017;9(11). Pii: E157. Doi: 10.3390/cancers9110157. PMID: 29144412. 
  • Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells. Tjomsland V, Aasrum M, Christoffersen T, Gladhaug IP. Oncotarget 2017;8:71672-84. Doi: 10.18632/oncotarget.17800. PMID: 29069737.
  • The TGFβ-SMAD3 pathway inhibits IL-1α induced intereactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration. Tjomsland V, Sandnes D, Pomianowska E, Cizmovic ST, Aasrum M, Brusevold IJ, Christoffersen T, Gladhaug IP. J Exp Clin Cancer Res 2016;35:122. Doi: 10.1186/s13046-016-0400-5.
  • Profile of MMP and TIMP expression in human pancreatic stellate cells: Regulation by IL-1α and TGFβ and implications for migration of pancreatic cancer cells. Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP. Neoplasia 2016;18:447-56. Doi: 10.1016/j.neo.2016.06.003. PMID: 27435927

  • Morphological heterogeneity in ductal adenocarcinoma of the pancreas – Does it matter? Verbeke C. Pancreatology 2016;16:295-301. Doi: 10.1016/j.pan.2016.02.004. PMID: 26924665.

  • Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Verbeke C, Löhr M, Karlsson JS, Del Chiaro M. Cancer Treatment Reviews 2015;41:17-26. Doi: 10.1016/j.ctrv.2014.11.002. PMID: 25434282.

  • Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma. Pomianowska E, Sandnes D, Grzyb K, Schjølberg AR, Aasrum M, Tveteraas IH, Tjomsland V, Christoffersen T, Gladhaug IP. BMC Cancer 2014;14:413. Doi: 10.1186/1471-2407-14-413. PMID: 24912820.

Publisert 10. apr. 2019 10:28 - Sist endret 14. feb. 2020 14:52